Mr. Byron D. Hewett has been Advisor of SomaLogic, Inc. since April 2017. Mr. Hewett served as the Chief Executive Officer of SomaLogic, Inc. from December 2, 2013 to April 2017. Mr. Hewett served as Executive Chairman at BioBehavioral Diagnostics Company since November 2008 and also as its Chief Executive Officer. Mr. Hewett served as the Chief Executive Officer of Immunicon Corp. since January 1, 2006 and as its President since April 2005.
Mr. Hewett has more than 20 years' experience in healthcare and life science general management, strategy formulation, business development and sales and marketing with firms including Qiagen, Inc., Bayer Diagnostics, Chiron Diagnostics, Metrika Inc., Biocircuits Corporation, Stericycle, Inc. and Abbott Laboratories and has commercial experience, almost entirely in the area of diagnostics.
Mr. Hewett served as Chief Operating Officer of Immunicon Corp. from October 12, 2004 to December 31, 2005 and served as its General Manager of Cancer Products from October 12, 2004 to April 2005. He was responsible for day-to-day management of cancer diagnostics and research products business in addition to line responsibility for operations, marketing and regulatory affairs of Immunicon Corp. From April 2002 to June 2004, he served as Senior Vice President of Sales and Marketing and General Manager, North America for Qiagen, Inc. where he led commercial North American operations with a staff of 250. Management responsibilities included oversight of sales, marketing, finance, human resources, IT, training and field, customer and technical service for both the US and Canada.
Prior to Qiagen, Mr. Hewett served as Vice President of Worldwide Marketing in the Laboratory Testing segment for Bayer Diagnostics from June 2000 t March 2002, responsible for strategy and marketing of its global immunochemistry, hematology, clinical chemistry, high volume urine chemistry, laboratory automation and information and consulting businesses. He served as President of the U.S commercial operations unit for Bayer and later served as a Vice President within the U.S. branch of the laboratory testing segment and nucleic acid diagnostics business.
Mr. Hewett began his career in 1978 in healthcare diagnostics with Abbott Laboratories where he stayed until 1991, advancing to the position of Business Unit Manager in its therapeutic drug monitoring and transport diagnostics business. He served as a Director of SomaLogic, Inc. until April 2017. He served as a Director at BioBehavioral Diagnostics Company. He served as a Director at Immunicon Corp. since January 1, 2006. Mr. Hewett received a Masters in Management degree from Northwestern University's J.L. Kellogg Graduate School of Management and a Bachelors of Science degree from the University of Virginia's McIntire School of Commerce.